openPR Logo
Press release

Good Growth Opportunities in Global Aptamers Market 2017 - 2021

06-08-2017 12:10 PM CET | Health & Medicine

Press release from: SA-BRC

Good Growth Opportunities in Global Aptamers Market 2017 - 2021

Aptamers are oligonucleotides or peptide bioreceptors that can selectively bind to specific molecular targets with high affinity. Aptamers have proved to be an excellent alternative to monoclonal antibodies. Due to its properties, aptamers have found application in therapeutic drug development, diagnostics, and biotechnology research and development. Aptamers are non-immunogenic, non-toxic and also have fewer side effects as compared to monoclonal antibodies because of the absence of Fc region. Smaller size permits easy entry of aptamers into the target cells and increases efficiency at lower concentrations. Due to their thermal stability, aptamers remain viable during transport and storage. Moreover aptamers are manufactured through chemical synthesis process hence have lower cost of production. This also allows easy scale-up of manufacturing process that is very difficult with monoclonal antibodies. These factors have made aptamers as excellent candidates for therapeutic drug development.

Various research institutes and pharma companies are conducting rigorous research for development of aptamers cancer treatment. Numerous companies have invested heavily in aptamers drug development. AptaTargets a Spanish biopharmaceutical company raised over US$ 3 million in funding in May 2017. The company plans to use these finds for conducting preclinical phase and advance into phase I and phase II clinical trials on its first drug candidate ApTOLL that is targeted for treatment of acute ischemic stroke. NOXXON and Anisoma are other key companies involved in therapeutic aptamers research. With increasing research and development activities and scientific publications advocating importance of aptamers in therapeutics, companies specializing in large scale aptamer manufacturing have emerged in the recent past. This has boosted the contract manufacturing organization (CMO) business. Currently systematic evolution of ligands by exponential enrichment (SELEX) method is widely used for aptamer synthesis. Although various modified versions of the parent method have evolved, it is expected that more productive and cost effective alternatives would emerge in the future. This would fuel the global aptamers market.

Request Free Report Sample@

Discovery of biomarkers that play important role in disease progression has contributed immensely to development of target therapy. Diseases such as cancer, autoimmune diseases, viral diseases, cardiac disorders and neurology disorders have been main attraction for development of aptamer targeted therapy. Aptamers are forecast to become an inevitable part of targeted therapy in the near future. Treatment of viral infections is an emerging application of aptamers; however majority of the research is focused on human immunodeficiency virus (HIV), Hepatitis C virus (HCV), and Hepatitis B virus (HBV).

Key players in the aptamers market include NOXXON Pharma AG, Ophthotech Corp, Archemix (Baxter), NeXstar (Gilead), AptaMatrix, Aptus Biotech, Base Pair Biotechnologies and Vivonics among others.

Request For TOC@

NOTE: This report is currently under research and will be made available to clients on request.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
Office No. 14,
Hermes Kunj, Mangaldas Road,
Pune, 411001
Phone: +91-02041210872

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Good Growth Opportunities in Global Aptamers Market 2017 - 2021 here

News-ID: 569615 • Views: 372

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases

More Releases for Aptamers

Aptamers Market : Trends and Future Applications
The global aptamers market is expected to witness a probable increase in demand and hence growth which is influenced by factors associated with the aptamer product. The increase in the research and development activities along with increase in the investments in the biotechnological and pharmaceutical companies has driven the use of aptamers and hence the global aptamer market. Other advantages such as technological advancements followed by patent expiration of SELEX
Comprehensive Industry Report Offers Forecast and Analysis on Aptamers Market
Aptamers are oligonucleotides or peptide molecules that bind to target lipid, protein, or nucleic acid molecules with a high specificity. Aptamers are generated rapidly and applied in the inhibition, specific detection, and characterization of proteins. Aptamers can be used as detection reagents, pharmaceutical leads, and functional proteomic levels with antibodies, small molecules, and other aptamers. Aptamers can be engineered to have higher affinity and specificity to large number of targets.
Aptamers Market - Global Industry Analysis 2025
Aptamers Market: New Innovative Solution for Diverse Medical Applications Aptamers are short single-stranded DNA or RNA (ssDNA or ssRNA) molecules that bind to a specific target protein, lipid, or nucleic acid molecules with high specificity. Aptamers can also be conjugated to drugs, working as drug-delivery systems. For example, aptamers have been conjugated with chemotherapy drugs to turn target and bind to only cancerous cells and leave healthy tissue untouched. Further, factors
02-04-2018 | Health & Medicine
Aptamers Market Trand and Analysis to 2019
The growing use of aptamers in drug discovery, pharmaceutical studies, as well as disease treatment will help drive the global aptamers market through the current decade, says Transparency Market Research in a recent study. The report is titled ‘Aptamers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.’ According to the report, the global aptamers market was valued at US$93.0 million in 2012, and it is expected
Aptamers Market Analysis & Key Trends 2019
As stated in the report, the market for aptamers is fuelled by the rising interest of a number of research scientists in aptamer technology due to their numerous benefits over other antibodies. In addition, the growing participation and support from various private organizations in order to bring in advancements within the aptamers field will further fuel the global aptamers market. Furthermore, modifications within the aptamer chemistry resulting in increased acceptance
Aptamers Market Research Report by Key Players Analysis 2019
The global aptamers market was valued at US$93.0 million in 2012, and it is expected that the market will reach a valuation of US$4,333.0 million by 2019. This translates to a remarkable CAGR of 73.1% between 2013 and 2019. However, the report also warns that the growth in the global aptamers market will be restrained to some extent ethical issues associated with aptamers derived from animals. This drawback will be further